NIH clinical trial to test antibodies and other experimental therapeutics for mild and moderate COVID-19
04/08/2020
Initial trial to determine if monoclonal antibodies can shorten severity of COVID-19 in outpatients.
Initial trial to determine if monoclonal antibodies can shorten severity of COVID-19 in outpatients.